Toilet Phobia Booklet
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Clinically Significant Avoidance of Public
Journal of Anxiety Disorders 23 (2009) 1170–1176 Contents lists available at ScienceDirect Journal of Anxiety Disorders Clinically significant avoidance of public transport following the London bombings: Travel phobia or subthreshold posttraumatic stress disorder? Rachel V. Handley a,*, Paul M. Salkovskis a, Peter Scragg b, Anke Ehlers a a King’s College London, Institute of Psychiatry, Department of Psychology, and Centre for Anxiety Disorders and Trauma, London, UK b Trauma Clinic, London, UK ARTICLEI NFO ABSTRA CT Article history: Following the London bombings of 7 July 2005 a ‘‘screen and treat’’ program was set up with the aim of Received 6 March 2008 providing rapid treatment for psychological responses in individuals directly affected. The present study Received in revised form 28 July 2009 found that 45% of the 596 respondents to the screening program reported phobic fear of public transport Accepted 28 July 2009 in a screening questionnaire. The screening program identified 255 bombing survivors who needed treatment for a psychological disorder. Of these, 20 (8%) suffered from clinically significant travel phobia. Keywords: However, many of these individuals also reported symptoms of posttraumatic stress disorder [PTSD]. Terrorist violence Comparisons between the travel phobia group and a sex-matched group of bombing survivors with PTSD Specific phobia showed that the travel phobic group reported fewer re-experiencing and arousal symptoms on the Posttraumatic stress disorder Screening Trauma Screening Questionnaire (Brewin et al., 2002). The only PTSD symptoms that differentiated the groups were anger problems and feeling upset by reminders of the bombings. There was no difference between the groups in the reported severity of trauma or in presence of daily transport difficulties. -
Department of Veterans Affairs § 4.130
Department of Veterans Affairs § 4.130 than 50 percent and schedule an exam- upon the Diagnostic and Statistical ination within the six month period Manual of Mental Disorders, Fourth following the veteran’s discharge to de- Edition, of the American Psychiatric termine whether a change in evalua- Association (DSM-IV). Rating agencies tion is warranted. must be thoroughly familiar with this (Authority: 38 U.S.C. 1155) manual to properly implement the di- rectives in § 4.125 through § 4.129 and to [61 FR 52700, Oct. 8, 1996] apply the general rating formula for § 4.130 Schedule of ratings—mental mental disorders in § 4.130. The sched- disorders. ule for rating for mental disorders is The nomenclature employed in this set forth as follows: portion of the rating schedule is based Rating Schizophrenia and Other Psychotic Disorders 9201 Schizophrenia, disorganized type 9202 Schizophrenia, catatonic type 9203 Schizophrenia, paranoid type 9204 Schizophrenia, undifferentiated type 9205 Schizophrenia, residual type; other and unspecified types 9208 Delusional disorder 9210 Psychotic disorder, not otherwise specified (atypical psychosis) 9211 Schizoaffective disorder Delirium, Dementia, and Amnestic and Other Cognitive Disorders 9300 Delirium 9301 Dementia due to infection (HIV infection, syphilis, or other systemic or intracranial infections) 9304 Dementia due to head trauma 9305 Vascular dementia 9310 Dementia of unknown etiology 9312 Dementia of the Alzheimer’s type 9326 Dementia due to other neurologic or general medical conditions (endocrine -
An Evidence Based Guide to Anxiety in Autism
Academic excellence for business and the professions The Autism Research Group An Evidence Based Guide to Anxiety in Autism Sebastian B Gaigg, Autism Research Group City, University of London Jane Crawford, Autism and Social Communication Team West Sussex County Council Helen Cottell, Autism and Social Communication Team West Sussex County Council www.city.ac.uk November 2018 Foreword Over the past 10-15 years, research has confirmed what many parents and teachers have long suspected – that many autistic children often experience very significant levels of anxiety. This guide provides an overview of what is currently known about anxiety in autism; how common it is, what causes it, and what strategies might help to manage and reduce it. By combining the latest research evidence with experience based recommendations for best practice, the aim of this guide is to help educators and other professionals make informed decisions about how to promote mental health and well-being in autistic children under their care. 3 Contents What do we know about anxiety in autism? 5 What is anxiety? 5 How common is anxiety and what does it look like in autism? 6 What causes anxiety in autism? 7-9 Implications for treatment approaches 10 Cognitive Behaviour Therapy 10 Coping with uncertainity 11 Mindfulness based therapy 11 Tools to support the management of anxiety in autism 12 Sensory processing toolbox 12-13 Emotional awareness and alexithymia toolbox 14-15 Intolerance of uncertainty toolbox 16-17 Additional resources and further reading 18-19 A note on language in this guide There are different preferences among members of the autism community about whether identity-first (‘autistic person’) or person-first (‘person with autism’) language should be used to describe individuals who have received an autism spectrum diagnosis. -
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
Medication-Assisted Treatment For Opioid Addiction in Opioid Treatment Programs A Treatment Improvement Protocol TIP 43 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment MEDICATION- www.samhsa.gov ASSISTED TREATMENT Medication-Assisted Treatment For Opioid Addiction in Opioid Treatment Programs Steven L. Batki, M.D. Consensus Panel Chair Janice F. Kauffman, R.N., M.P.H., LADC, CAS Consensus Panel Co-Chair Ira Marion, M.A. Consensus Panel Co-Chair Mark W. Parrino, M.P.A. Consensus Panel Co-Chair George E. Woody, M.D. Consensus Panel Co-Chair A Treatment Improvement Protocol TIP 43 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment 1 Choke Cherry Road Rockville, MD 20857 Acknowledgments The guidelines in this document should not be considered substitutes for individualized client Numerous people contributed to the care and treatment decisions. development of this Treatment Improvement Protocol (see pp. xi and xiii as well as Appendixes E and F). This publication was Public Domain Notice produced by Johnson, Bassin & Shaw, Inc. All materials appearing in this volume except (JBS), under the Knowledge Application those taken directly from copyrighted sources Program (KAP) contract numbers 270-99- are in the public domain and may be reproduced 7072 and 270-04-7049 with the Substance or copied without permission from SAMHSA/ Abuse and Mental Health Services CSAT or the authors. Do not reproduce or Administration (SAMHSA), U.S. Department distribute this publication for a fee without of Health and Human Services (DHHS). -
Lodico of UR MG Public Comments August 7. 2015
Oral Fluid/Urine Proposed Mandatory Guidelines Federal Register Notices: Summary of Public Comments Presented by Charles LoDico, M.S., F-ABFT Division of Workplace Programs August 7, 2015 Drug Testing Advisory Board Federal Register Notices 2 • HHS published two Federal Register Notices on May 15, 2015 • Proposed revisions to the Mandatory Guidelines for Federal Workplace Drug Testing Programs using Urine (URMG); 94 FR 28101 • Proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs using Oral Fluid (OFMG); 94 FR 28054 Public Comments 3 • HHS requested public comment on all aspects of the two Notices • Public comments were accepted until July 14, 2015 (60 days) at http://www.regulations.gov • HHS also specifically requested comment on certain items in the URMG and OFMG HHS URMG Specific Comments 4 • Change cutoff for pH adulterated • ≤ 4 and ≥ 11 • Requalification of MROs • Training and re-exam • 5 years after initial re-qualification URMG Public Comments 5 • 123 commenters • 427 comments • This includes comments relevant to urine that were submitted under the oral fluid FRN URMG Commenters 6 • 123 URMG commenters • 104 Individuals • 9 Professional organizations • 2 HHS-certified laboratories • 1 Collection site • 2 Employers • 5 MROs and/or TPAs Professional Organizations 7 • Airlines for America • Air Line Pilots Association, International • Association of Flight Attendants - CWA • American College of Occupational & Environmental Medicine • International Paruresis Association • National Safety Council • National School -
Statistical Analysis Plan
CONFIDENTIAL 2020N435253_00 The GlaxoSmithKline group of companies 206898 Division : Worldwide Development Information Type : Reporting and Analysis Plan (RAP) Title : Reporting and Analysis Plan for 206898: An Open Label, Phase 1 Study to Evaluate the PK, Safety, Tolerability and Acceptability of Long Acting Injections of the HIV Integrase Inhibitor, Cabotegravir (CAB; GSK1265744) in HIV Uninfected Chinese Men Compound Number : GSK1265744 Effective Date : 22-APR-2019 Description: The purpose of this RAP is to describe the planned analyses and output to be included in the Clinical Study Report for Protocol 206898. This RAP is intended to describe the safety, tolerability, and pharmacokinetic (PK) analyses required for the study. This RAP will be provided to the study team members to convey the content of the Statistical Analysis Complete (SAC) deliverable. Author’s Name and Functional Area: PPD 22-APR-2019 Senior Biostatistician, PPD PPD 22-APR-2019 Pharmacokineticist (Biostatistics, PPD) Approved by: PPD 22-APR-2019 Statistics Leader, GSK PPD 22-APR-2019 Manager Statistics Copyright 2019 the GlaxoSmithKline group of companies. All rights reserved. Unauthorised copying or use of this information is prohibited. 1 CONFIDENTIAL 2020N435253_00 206898 TABLE OF CONTENTS PAGE 1. REPORTING & ANALYSIS PLAN SYNOPSIS.........................................................5 2. SUMMARY OF KEY PROTOCOL INFORMATION ..................................................8 2.1. Changes to the Protocol Defined Statistical Analysis Plan ............................8 -
The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic Criteria for Research
The ICD-10 Classification of Mental and Behavioural Disorders Diagnostic criteria for research World Health Organization Geneva The World Health Organization is a specialized agency of the United Nations with primary responsibility for international health matters and public health. Through this organization, which was created in 1948, the health professions of some 180 countries exchange their knowledge and experience with the aim of making possible the attainment by all citizens of the world by the year 2000 of a level of health that will permit them to lead a socially and economically productive life. By means of direct technical cooperation with its Member States, and by stimulating such cooperation among them, WHO promotes the development of comprehensive health services, the prevention and control of diseases, the improvement of environmental conditions, the development of human resources for health, the coordination and development of biomedical and health services research, and the planning and implementation of health programmes. These broad fields of endeavour encompass a wide variety of activities, such as developing systems of primary health care that reach the whole population of Member countries; promoting the health of mothers and children; combating malnutrition; controlling malaria and other communicable diseases including tuberculosis and leprosy; coordinating the global strategy for the prevention and control of AIDS; having achieved the eradication of smallpox, promoting mass immunization against a number of other -
A Cognitivebehavioural Perspective on Personality Disorders With
Personality and Mental Health 6: 170–173 (2012) Published online in Wiley Online Library (wileyonlinelibrary.com) DOI 10.1002/pmh.1195 Commentary A cognitive-behavioural perspective on Personality disorders with over-regulation of emotions and poor self-reflectivity: The case of a man with avoidant and not-otherwise specified personality disorder, social phobia and dysthymia treated with Metacognitive Interpersonal Therapy RICKS WARREN, University of Michigan, Department of Psychiatry, Ann Arbor, MI 48109-2700, USA Dimaggio, Attina, Popolo, Salvatore and Procacci and Fonagy (2000). Treatments should be well- (2012) present a complex case of primarily structured,concentrate on enhancing compliance, avoidant personality disorder (AvPD) with addi- have a clear focus, be theoretically coherent to both tional dependent, depressive, paranoid and therapist and patient, be relatively long-term, passive–aggressive personality traits, along with encourage a powerful attachment relationship dysthymia, social phobia and erectile dysfunction. between therapist and patient and involve an active As the authors note, there is no treatment manual therapist stance (Silk, 2010). At the end of 1 year of for such complex cases, and Metacognitive treatment, the patient is reported to no longer suffer Interpersonal Therapy (MIT) seems appropriate from any personality disorder, and improvement in for the case presented. As Emmelkamp et al. social phobia and sexual problems also were (2006) have noted, AvPD is highly prevalent in obtained. Given such a complex case with apparent the community and is associated with even more failure to make clinically significant gains in 5 years impairment than major depression. Of all the of previous CBT for social phobia, the potency of personality disorders, it is the most persistent, and MIT is well supported. -
An Exploratory Investigation Into the Potential of Mobile Virtual Reality for the Treatment of Paruresis – a Social Anxiety Disorder J Lewis, a Paul, D Brown
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Nottingham Trent Institutional Repository (IRep) An Exploratory Investigation into the Potential of Mobile Virtual Reality for the Treatment of Paruresis – a Social Anxiety Disorder J Lewis, A Paul, D Brown Department of Computing, Nottingham Trent University Nottingham UK [email protected] www.ntu.ac.uk ABSTRACT This paper describes the initial exploratory phase of developing a VR intervention designed to alleviate the problems people with Paruresis experience when they need to utilise public toilet facilities. The first phase of the study produced a virtual environment, based upon a public toilet, which would run on the widely available Gear VR or Oculus Go HMD. The purpose of this prototype was to facilitate an informed discussion with a focus group of Paruresis patients, to obtain preliminary conclusions on whether they were interested in such an intervention and whether it offered potential to help alleviate the condition. In partnership with the UK Paruresis Trust the software was reviewed by both potential users and domain specialists. Results showed that the majority of participants reported a stress response to the stimulus of the virtual public toilet, indicating that it could be effective as a platform for graduated exposure therapy. Focus group feedback, and input from domain experts, was utilised as part of a participatory design methodology to guide the priorities for a second phase of development. The exploratory study concluded that this approach offers great potential as a future treatment for people with Paruresis 1. INTRODUCTION Paruresis is a specific type of social anxiety disorder, also known as Shy Bladder Syndrome. -
Psychological and Functional Disorder Co-Morbidities in Idiopathic Urinary Retention
Psychological and functional disorder co-morbidities in idiopathic urinary retention: International Consultation on Incontinence Research Society (ICI-RS) 2019 Running title: Psychological and functional disorder co-morbidities in urinary retention Jalesh N. Panicker1, Caroline Selai2, Francois Herve3, Kevin Rademakers4 Roger Dmochowski5, Tufan Tarcan6, Alexander von Gontard7, Desiree Vrijens8 1Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery and UCL Queen Square Institute of Neurology, London, United Kingdom 2Department of Clinical and Movement Neurosciences and Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery and UCL Queen Square Institute of Neurology, London, United Kingdom 3 Urology Department, Cliniques Universitaires Saint Luc, Brussels, Belgium 4 Department of Urology, Zuyderland Medical Centre, Sittard/Heerlen, Netherlands 5 Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, USA 6 Department of Urology, Marmara University School of Medicine, Istanbul, Turkey 7Department of Child and Adolescent Psychiatry, Saarland University Hospital, 66121 Homburg, Germany 8Department of Urology, Maastricht University Medical Centre, Maastricht, The Netherlands Word count: 3250 Key word: Psychological disorders, anxiety, functional neurological symptom disorders, FND, somatization, urinary retention Corresponding author: Jalesh N. Panicker, Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom Email: [email protected] Telephone: +44(0)2034484713 Abstract Aims: Urinary retention occurring in young women is often poorly understood and a cause may not be found in a majority of cases despite an extensive search for urological and neurological causes. Different psychological co- morbidities and functional neurological symptom disorders (FNDs) have been reported in women with idiopathic urinary retention, however these have been poorly explored. -
Social Phobias Pp
WINTER 2020 BalancedLiving Social Phobias pp. 6-7 Understanding Dementia: Tips for Caregivers pp. 8-9 ...Also In this issue... Why I Use Psychotherapy Stress Signals MINES Eye: 10 Minute Mindfulness Walk & Brief Meditation BalancedLiving WINTER 2020 MINES & Associates 10367 West Centennial Road Littleton, Colorado 80127 800.873.7138 www.MINESandAssociates.com . CREDITS . A word from your Employee Assistance Program... The Staywell Company, LLC ©2020 Why I Use Psychotherapy pg. 4 Welcome to the Winter 2020 issue of BalancedLiving! Stress Signals pg. 5 National Institute of Mental Health 2020 has been a challenging year for all of us, but we hope (NIMH) ©2020 that the resources we provide in this publication, as well as Social Phobias pp. 6-7 the services that MINES provides you through the EAP have Life Advantages - Author Delvina Miremadi ©2020 Understanding Dementia: Tips for whenhelped it to comes, make developit easier. yourTo help mindfulness finish out theskills, year and strong provide we Caregivers pp. 8-9 somehave fill support this issue to caregivers with more that resources are caring to help for lovedmanage ones! stress The MINES Team MINES Eye: 10 Minute Mindfulness Walk On page 4 we start off with an article talking about why & Brief Meditation pg. 10 someone may want to use therapy and how it can be useful. Next we look at the stress signals our body gives us when we www.food.com Recipe: Traditional Irish Shepherd’s Pie are under pressure. On page 6 there is a discussion on social pg. 11 phobias, on of the most common of all phobias. -
Major Depressive and Anxiety Disorders in Visually Impaired Older Adults
Low Vision Major Depressive and Anxiety Disorders in Visually Impaired Older Adults Hilde P. A. van der Aa,1,2 Hannie C. Comijs,2,3 Brenda W. J. H. Penninx,2,3 Ger H. M. B. van Rens,1,2,4 and Ruth M. A. van Nispen1,2 1Department of Ophthalmology, VU University Medical Center, Amsterdam, The Netherlands 2EMGOþ Institute for Health and Care Research (EMGOþ), VU University Medical Center, Amsterdam, The Netherlands 3Department Psychiatry VUmc/GGZinGeest, Amsterdam, The Netherlands 4Department of Ophthalmology, Elkerliek Hospital, Helmond, The Netherlands Correspondence: Hilde PA van der PURPOSE. We assessed the prevalence of subthreshold depression and anxiety, and major Aa, VU University Medical Center, De depressive, dysthymic, and anxiety disorders (panic disorder, agoraphobia, social phobia, and Boelelaan 1117, 1081 HV Amster- general anxiety disorder) in visually impaired older adults and compared these estimates with dam, The Netherlands; those of normally sighted peers. [email protected]. METHODS. Cross-sectional data were analyzed based on telephone interviews with visually Submitted: October 10, 2014 Accepted: January 6, 2015 impaired older adults aged ‡ 60 years (n ¼ 615) with a visual acuity of ‡ 0.30 logMAR (20/40 Snellen) in the best eye from outpatient low vision rehabilitation centers, and face-to-face Citation: van der Aa HPA, Comijs HC, interviews with community-dwelling normally sighted peers (n ¼ 1232). To determine Penninx BWJH, van Rens GHMB, van prevalence rates, the normally sighted population was weighted on sex and age to fit the Nispen RMA. Major depressive and visually impaired population. Logistic regression analyses were used to compare the anxiety disorders in visually impaired older adults.